Omalizumab (rch) (immune-system-modifying medicines)

Omalizumab (rch) (immune-system-modifying medicines) is an active ingredient that is used in some medicines.

The active ingredient is the chemical in a medicine that makes it work. Medicines can have more than one active ingredient and be available under different brand names. Medicines include both active ingredients and inactive ingredients.

This page about omalizumab (rch) (immune-system-modifying medicines) automatically lists related information collected from other pages of our website.

You'll find information about brands of medicines that contain this combination of active ingredients, including their consumer medicine information (CMI) leaflets by following the links below.

Consumers: If you have any questions about medicines, you can speak to one of our pharmacists at NPS Medicines Line by calling 1300 633 424. You can ring Monday to Friday, 9 am to 5 pm, Australian Eastern Standard Time (excluding NSW public holidays). For non-medicine products, further information may also be available from the manufacturer.

Related information - omalizumab (rch) (immune-system-modifying medicines)

Audience:
       

(Medicine)
02 Nov 2016 Xolair Vial (Powder for injection) (immune-system-modifying medicines) is a brand of medicine. Find out about side effects, who can and who shouldn’t use Xolair Vial (Powder for injection) (immune-system-modifying medicines) by reading the latest Australian consumer medicine information. See our tips on how to use medicines wisely and safely.
(Medicine)
02 Nov 2016 Xolair Prefilled Syringe (Solution for injection) (immune-system-modifying medicines) is a brand of medicine. Find out about side effects, who can and who shouldn’t use Xolair Prefilled Syringe (Solution for injection) (immune-system-modifying medicines) by reading the latest Australian consumer medicine information. See our tips on how to use medicines wisely and safely.
(Medicine)
30 Apr 2014 Find out about the asthma medicines you may be prescribed if you are not achieving good asthma control, or if you are hospitalised with an asthma attack.

Medicine brands that contain omalizumab (rch) (immune-system-modifying medicines)